| Survival: | 10.0 months |
| Toxicity Grade: | 4 |
| Treatments: | Chemotherapy |
| Drugs: | IFEX |
| Country: | Denmark |
| City/State/Province: | Copenhagen |
| Hospital: | National University Hospital, Rigshospitalet |
| Journal: | Link |
| Date: | 4/1999 |
| Description: |
| Patients: This Phase II study involved 26 patients with malignant mesothelioma. (24 patients had pleural mesothelioma.) Treatment: The treatment consisted of administration of the chemotherapy drug, Ifosfamide (IFEX). Toxicity: Grade 3-4 toxicities included leucopenia, infection, nausea/vomiting, diarrhea, neurotoxicity, renal, hematuria, and alopecia. Results: The median overall survival was 10 months. |